Topical application of nerve labeling dyes for image-guided surgery
AssigneeGeneral Electric Company
InventorsCristina Abucay Tan Hehir, Tiberiu Mircea Siclovan, Victoria Eugenia Cotero
Life of this patent
Estimating the term…
Abstract
The present invention relates to a topical agent that binds specifically to myelin basic protein and its method of use and determining myelination in the subject by detecting the agent present in the subject. A kit containing the agent or its derivatives for use in detecting myelin basic protein is also provided.
Claims24
A topical administered pharmaceutical agent comprising a compound of Formula I or a salt thereof, wherein Formula I is:
- wherein R1 is an alkyl group, R2 is an electron donating group and R3 is an electron withdrawing group;
- and
- an aqueous pharmaceutical carrier comprising, based on volume:
- 1-30% PEG-300, 1-20% propylene glycol, 1-10% polyvinylpyrrolidone, and 0-10% Laurocapram.
A method of imaging myelin basic protein in an open or minimally invasive surgical field by topical administration of a pharmaceutical agent comprising the steps of:
- contacting the surgical field with a pharmaceutical agent, said agent comprising a compound of Formula I or a salt thereof, wherein Formula I is:
- wherein R1 is an alkyl group, R2 is an electron donating group and R3 is an electron withdrawing group;
- and
- an aqueous pharmaceutical carrier comprising, based on volume:
- 10-30% PEG-300 and 5-20% polyvinyl alcohol;
- detecting the agent by applying a light source tuned to the spectral excitation characteristics of the agent;
- and observing a subject through an optical filter tuned to the spectral emission characteristics of the agent.
A kit for providing a topical administered pharmaceutical agent comprising:
- a compound of Formula I or a salt thereof, wherein Formula I is:
- wherein R1 is an alkyl group, R2 is an electron donating group and R3 is an electron withdrawing group;
- an aqueous pharmaceutical carrier comprising, based on volume:
- 1-30% PEG-300, 1-20% propylene glycol, 1-10% polyvinylpyrrolidone, and 0-10% Laurocapram;
- and
- a co-solvent, surfactant, buffer solution, stabilizer, preservative, or any combination thereof.
Dependencies are inferred from the claim text.